Dissolving stent with drug for blocked heart arteries
Part of Heart & circulation clinical trials.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blocked heart artery that needs a stent.
- The blockage is new, not one that already had a stent.
- The artery is between 2.5 and 4 mm wide, and the blockage is 25 mm or shorter.
- The blockage is not in the main left artery, at the very beginning of a vessel, or in a bypass graft.
- You are 18 to 75 years old, not pregnant, and able to take blood thinners.
- You have not had a stent in the same artery in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
This study looks at how to treat blocked heart arteries that have narrowed again after a prior drug-eluting stent. It compares using another drug-eluting stent versus a drug-coated balloon, chosen based on an imaging scan inside the artery (OCT), to reduce repeat narrowing.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial tests a new stent system for treating narrowed heart arteries. If you have coronary artery disease with one or two blockages that are at least 70% narrowed, this procedure might be an option for you.
This study tests a new kind of coronary stent that slowly releases rapamycin to keep an artery open. You may be invited if you have a small number of specific, treatable blockages and can take the required blood-thinning medicines.
This trial tests whether a special drug-coated balloon (“MagicTouch”) can treat re-narrowing inside a previously placed stent. It may help patients whose stent has become blocked again, by improving blood flow and reducing repeat narrowing.
Hear when a new De Novo Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.